- Home
- HVT vs STRO Comparison
HVT vs STRO Comparison
Compare HVT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | STRO |
|---|---|---|
| Founded | 1885 | 2003 |
| Country | United States | United States |
| Employees | 2334 | 131 |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.2M | 338.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HVT | STRO |
|---|---|---|
| Price | $20.83 | $23.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $26.38 |
| AVG Volume (30 Days) | 134.8K | ★ 170.2K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.83 | N/A |
| Revenue Next Year | $8.70 | $13.45 |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.01 | $0.52 |
| 52 Week High | $27.67 | $27.96 |
Technical Indicators
Market Signals| Indicator | HVT | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 56.60 |
| Support Level | $19.78 | $0.76 |
| Resistance Level | $20.99 | $27.96 |
| Average True Range (ATR) | 0.75 | 2.12 |
| MACD | 0.12 | -0.13 |
| Stochastic Oscillator | 28.25 | 63.58 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.